CUV 3.38% $13.99 clinuvel pharmaceuticals limited

Looks like someone is helping themselves to some cheap shares...

  1. 842 Posts.
    lightbulb Created with Sketch. 1149


    Looks like someone is helping themselves to some cheap shares today, the shorters position at these levels is slightly tenuous IMO. Look at Nanosonics today, up nearly 20% to a market cap of $1 Billion. They had a mere 2% increase in revenue and NPAT fell 35% to $13 Million - compare to to CUV who will have somewhere between double or triple those profits and are running a Phase 3 blockbuster with an already FDA approved drug amongst other things and we can hope for some green - especially if Clinuvel gets cracking with buying back 1.5 Million shares over the next half year. Going to be interesting.

    All IMO DYOR
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.